Facephi Biometria, S.A.

EPA:ALPHI.PA

1.58 (EUR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q32023 Q22023 Q12022 Q4
Revenue 8.7378.7375.9255.9258.193
Cost of Revenue 0.7630.7630.950.950.899
Gross Profit 7.9747.9744.9754.9757.295
Gross Profit Ratio 0.9130.9130.840.840.89
Reseach & Development Expenses 1.0481.0481.051.050
General & Administrative Expenses 3.9613.961003.708
Selling & Marketing Expenses 0.6120.612000.512
SG&A 4.5734.5733.4553.4554.22
Other Expenses 3.0043.0042.5112.5112.003
Operating Expenses 8.6258.6257.0167.0166.223
Operating Income -0.651-0.651-2.041-2.0411.072
Operating Income Ratio -0.075-0.075-0.344-0.3440.131
Total Other Income Expenses Net -0.62-0.62-0.215-0.215-0.1
Income Before Tax -1.271-1.271-2.257-2.2570.972
Income Before Tax Ratio -0.145-0.145-0.381-0.3810.119
Income Tax Expense 1.4641.4640.0910.0910.116
Net Income 0.1930.193-2.348-2.3481.088
Net Income Ratio 0.0220.022-0.396-0.3960.133
EPS 0.0090.009-0.122-0.1290.067
EPS Diluted 0.0090.009-0.122-0.1290.067
EBITDA -0.557-0.68-1.436-1.4361.079
EBITDA Ratio -0.064-0.078-0.242-0.2420.132